Search results for: 'deaf texas and benchmarking'
- Did you mean
- deal terms and benchmarking
- Related search terms
- deaf and alliance
- deaf+and+alliance
- deaf+texas+and+benchmarking
- deaf+teva+and+benchmarking
- texas in therapeutics partnering 221b 221b
-
Companion Diagnostic Collaboration and Licensing Deals 2010-2024May 2024$3,995.00Companion Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Gastrointestinal Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Gastrointestinal Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Diagnostic Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Precision Medicine in Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024
Learn More -
Genomic Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
